News Daily News Injectable Semaglutide Shortage Forces Physicians to Pivot Todd Neale February 05, 2024
News Daily News BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes Todd Neale February 02, 2024
News Daily News Universal Risk Tool Works Well in Both Primary and Secondary Prevention Michael O'Riordan February 01, 2024
News Daily News Short Bouts of Physical Activity May Offset Occupational Sitting CVD Risks L.A. McKeown January 24, 2024
News Daily News GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks Todd Neale January 21, 2024
News Daily News FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions Todd Neale January 12, 2024
News Daily News Counting Quality, Not Carbs, May Be Key to Weight Management L.A. McKeown January 05, 2024
News Daily News Top General Cardiology and CVD Prevention News of 2023 Yael L. Maxwell January 03, 2024
News Daily News Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies Michael O'Riordan December 19, 2023
News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023
News Daily News Slight Shift Seen After Calories Added to Fast-food Menus L.A. McKeown December 15, 2023
News Daily News Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk Todd Neale December 12, 2023
News Daily News Optimal Care Reported in Less Than Half of Adults With ASCVD Yael L. Maxwell December 05, 2023
News Daily News Oral GLP-1 Drug Danuglipron to Move Forward, but With Tweaks to Dose L.A. McKeown December 01, 2023
News Daily News New AF Guideline Emphasizes Early Rhythm Control, Elevates Ablation and LAAO Todd Neale November 30, 2023
News Daily News ‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults Michael O'Riordan November 21, 2023
News Daily News Mortality Risk Varies Among Patients With Very High LDL Levels Michael O'Riordan November 17, 2023
News Daily News FDA Grants Tirzepatide a New Indication for Obesity Management L.A. McKeown November 08, 2023